This site was designed with the
.com
website builder. Create your website today.
Start Now
  • HOME

  • ABOUT

  • CONTACT

  • More

    Use tab to navigate through the menu items.

    EyeBytes

    Website Logo
     eye research and news
    FDA Panel Unanimously Supports Luxturna Gene Therapy

    FDA Panel Unanimously Supports Luxturna Gene Therapy

    An FDA advisory panel unanimously backed Spark Therapeutics Luxturna gene therapy for inherited retinal diseases. The one time treatment...
    Follow Us
    • Facebook Social Icon
    • LinkedIn Social Icon
    • Twitter Social Icon
    • Instagram Social Icon
    Featured Review
    World Sight Day 2021

    World Sight Day 2021

    Orthoptists authorised to join Australia's Covid-19 vaccination program

    Orthoptists authorised to join Australia's Covid-19 vaccination program

    Covid-19 Australia - Impact on Eye Care

    Covid-19 Australia - Impact on Eye Care

    Leadership Development for Women in STEM

    Leadership Development for Women in STEM

    8 Top Eye Apps

    8 Top Eye Apps

    Global Blindness Data Out

    Global Blindness Data Out

    Futurism

    Futurism

    The Art of Creating a Prosthesis

    The Art of Creating a Prosthesis

    Is SS-OCT the way of the future in ocular biometry?

    Is SS-OCT the way of the future in ocular biometry?

    Ground Breaking Research from Oxford

    Ground Breaking Research from Oxford

    What has been your favourite virtual conference for 2021?
    Virtual Team Meeting
    This Month's Favourite Journal 
    Ophthalmology journal cover
    Tag Cloud (Select one)
    • Covid-19
    • Leadership
    • WILD Program
    • gene therapy
    • Governance
    • Love Your Eyes
    • Luxturna
    • stroke
    • visual assessment
    • World Sight Day

    © 2017 by eyebytes 

    Melbourne, Australia

    ​

    email: info@eyebytes.com.au

    • Facebook Social Icon
    • LinkedIn Social Icon
    • Twitter Social Icon
    • Instagram Social Icon